Genetic sequencing for fetal structural problems
Part of Genetic & congenital, Women’s health & pregnancy clinical trials.
This study offers genetic sequencing to find the cause of certain serious fetal problems, such as structural anomalies, severe growth restriction, or unexplained pregnancy loss after 14 weeks. It aims to help families understand why the issue occurred and guide future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old and pregnant
- Your fetus is found to have a structural problem, unexplained death after 14 weeks, severe growth restriction, or too much amniotic fluid
- You agree to have diagnostic testing such as karyotype or microarray
- The fetal problem is not already explained by a virus or a known chromosome change
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the benefits of doing extra genetic testing (genomic sequencing) on samples from routine prenatal tests like CVS or amniocentesis, specifically for pregnancies where the baby appears normal on ultrasound.
This study uses advanced genetic testing (whole genome sequencing) on tissue samples from fetuses with structural abnormalities detected on ultrasound. The goal is to identify genetic causes of birth defects to help with diagnosis and understanding of your baby's condition.
This study looks for rare genetic changes that might explain birth defects when standard tests have not found a cause. It could help families understand why a baby has a structural problem and may guide future care.
This study uses advanced genetic testing on the fluid around the baby to look for rare diseases when an ultrasound shows possible problems. It aims to give more complete information to help you and your doctor make decisions during pregnancy.
This study looks at the genetic material in the fluid around the baby (amniotic fluid) and in the placenta to better understand complex heart defects in unborn babies. The goal is to find new clues that could help doctors care for these babies before and after birth.
This trial uses genetic testing to better understand the cause of a newborn’s birth defect and to help doctors choose more personalized treatment. It may help families get clearer answers and more targeted care.
Hear when a new Fetal Structural Anomalies trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.